AstraZeneca PLC (AZNCF)
130.24
+1.04
(+0.80%)
USD |
OTCM |
Nov 14, 16:00
AstraZeneca Total Liabilities (Quarterly): 64.74B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 64.74B |
| March 31, 2024 | 64.79B |
| December 31, 2023 | 61.95B |
| September 30, 2023 | 58.86B |
| June 30, 2023 | 59.13B |
| March 31, 2023 | 60.88B |
| December 31, 2022 | 59.42B |
| September 30, 2022 | 59.03B |
| June 30, 2022 | 60.63B |
| March 31, 2022 | 63.91B |
| December 31, 2021 | 66.08B |
| September 30, 2021 | 67.31B |
| June 30, 2021 | 57.95B |
| March 31, 2021 | 50.48B |
| December 31, 2020 | 51.09B |
| September 30, 2020 | 50.49B |
| June 30, 2020 | 46.27B |
| March 31, 2020 | 45.00B |
| December 31, 2019 | 46.78B |
| September 30, 2019 | 45.24B |
| June 30, 2019 | 46.82B |
| March 31, 2019 | 49.03B |
| December 31, 2018 | 46.61B |
| September 30, 2018 | 47.91B |
| June 30, 2018 | 47.07B |
| Date | Value |
|---|---|
| March 31, 2018 | 48.71B |
| December 31, 2017 | 46.71B |
| September 30, 2017 | 49.14B |
| June 30, 2017 | 49.71B |
| March 31, 2017 | 46.18B |
| December 31, 2016 | 45.86B |
| September 30, 2016 | 48.31B |
| June 30, 2016 | 49.03B |
| March 31, 2016 | 47.68B |
| December 31, 2015 | 41.55B |
| September 30, 2015 | 36.75B |
| June 30, 2015 | 36.87B |
| March 31, 2015 | 36.74B |
| December 31, 2014 | 38.95B |
| September 30, 2014 | 35.70B |
| June 30, 2014 | 36.49B |
| March 31, 2014 | 37.91B |
| December 31, 2013 | 32.65B |
| September 30, 2013 | 30.67B |
| June 30, 2013 | 30.58B |
| March 31, 2013 | 29.84B |
| December 31, 2012 | 29.59B |
| September 30, 2012 | 30.19B |
| June 30, 2012 | 29.15B |
| March 31, 2012 | 29.04B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
45.00B
Minimum
Mar 2020
67.31B
Maximum
Sep 2021
57.62B
Average
59.13B
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 225.43M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| Verona Pharma PLC | 251.33M |
| NuCana PLC | 20.58M |
| Autolus Therapeutics PLC | 325.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 104.34B |
| Shareholders Equity (Quarterly) | 39.51B |
| Debt to Equity Ratio | 0.8173 |
| Current Ratio | 0.8889 |
| Net Debt Paydown Yield | -0.14% |